Salivary biomarker testing in patients with Barrett's Oesophagus and Oesophageal Cancer
- Conditions
- Oesophageal cancerBarrett's OesophagusCancer - Oesophageal (gullet)Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12624000627550
- Lead Sponsor
- Royal Brisbane & Women's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 250
•Referral for investigation of reflux symptoms or other suspected gastrointestinal disease, as well as patients with established Barrett’s oesophagus and/or suspected or established oesophageal adenocarcinoma
•Age between 18 and 100 years old
•Willingness to participate for the duration of the trial period
•Provision of written Informed Consent for participation in this study
•Patients medically unsuitable for further testing or oesophageal screening, as determined by the treating clinician.
•High risk of poor compliance to participate with study requirements or follow-up as assessed by the investigator
•Current illness that will interfere with the collection of saliva, gastric secretions and/or blood samples
•Previous invasive malignancy within 5 years of current diagnosis with the exception of skin cancer other than melanoma.
•Previous cancer treatment in the last 5 years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method